NEWS TIPS & FEATURES

FDA Approves Keytruda® for Adult and Pediatric Patients with Classical Hodgkin

It was announced today that the U.S. Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab), an anti-PD-1 (programmed death receptor-1) therapy, for the treatment of adult and pediatric... [...]


Colon Cancer Surgery: Minimally Invasive Laparoscopic Surgery versus Open Colectomy

If you’ve been diagnosed with colon cancer and your healthcare team has determined that you’re a candidate for either complete or partial removal of your colon (colectomy) or a minimally invasive surgical... [...]


FDA Expands Indication for Revlimid® as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant

The U.S. Food and Drug Administration (FDA) expanded the existing indication for Revlimid® (lenalidomide) to include use for patients with multiple myeloma as maintenance therapy following autologous... [...]


Strategies to Help Get Your Thinking Back on Track

The recorded version of the webchat will be available here as soon as possible.   Cancer often causes changes in memory, word retrieval, planning, organization, and the ability to multi-task. These... [...]


SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy... [...]


Kyprolis® Significantly Improves Overall Survival Compared To Velcade® In Relapsed Or Refractory Multiple Myeloma

The ENDEAVOR trial results were updated at the 16th International Myeloma Workshop in New Delhi.  The trial demonstrated that Kyprolis (Carfilzomib) not only significantly extended progression-free survival... [...]


March is Multiple Myeloma Awareness Month: Learn About Recent Advances

There are several recent advances of note in the management of all stages of Multiple Myeloma. Smoldering myeloma is considered to be a pre-cancerous condition, in which patients do not yet display any... [...]


Lynparza Improves Progression-Free Survival in BRCA-Mutated Ovarian Cancer

Results were recently presented at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in National Harbor, USA, demonstrating that Lynparza (olaparib) reduced the risk of platinum-sensitive,... [...]


Kisqali® Receives FDA Approval as First Line Treatment for HR+/HER2- Metastatic Breast Cancer

The US Food and Drug Administration (FDA) has approved the investigational drug Kisqali® (ribociclib, LEE011) for first line treatment of hormone receptor + HER 2- metastatic breast cancer because when... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS